{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:20:14Z","timestamp":1792819214542,"version":"4.5.0"},"reference-count":156,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00011-022-01554-6","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T05:02:48Z","timestamp":1647493368000},"page":"537-554","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Role of the innate and adaptive immune responses in the pathogenesis of systemic lupus erythematosus"],"prefix":"10.1007","volume":"71","author":[{"given":"Nasim","family":"Bolouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Akhtari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4324-2697","authenticated-orcid":false,"given":"Elham","family":"Farhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Tahereh","family":"Faezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmadreza","family":"Jamshidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,17]]},"reference":[{"issue":"2","key":"1554_CR1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3390\/cells8020127","volume":"8","author":"B Richardson","year":"2019","unstructured":"Richardson B. Epigenetically altered T cells contribute to lupus flares. Cells. 2019;8(2):127.","journal-title":"Cells"},{"key":"1554_CR2","doi-asserted-by":"publisher","first-page":"4126106","DOI":"10.1155\/2018\/4126106","volume":"2018","author":"M Honarpisheh","year":"2018","unstructured":"Honarpisheh M, K\u00f6hler P, von Rauchhaupt E, Lech M. The involvement of microRNAs in modulation of innate and adaptive immunity in systemic lupus erythematosus and lupus nephritis. J Immunol Res. 2018;2018:4126106.","journal-title":"J Immunol Res"},{"issue":"9","key":"1554_CR3","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nrrheum.2017.125","volume":"13","author":"LA Trouw","year":"2017","unstructured":"Trouw LA, Pickering MC, Blom AM. The complement system as a potential therapeutic target in rheumatic disease. Nat Rev Rheumatol. 2017;13(9):538\u201347.","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"1554_CR4","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","volume":"12","author":"GC Tsokos","year":"2016","unstructured":"Tsokos GC, Lo MS, Costa Reis P, Sullivan KE. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol. 2016;12(12):716\u201330.","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"1554_CR5","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1136\/annrheumdis-2014-205287","volume":"73","author":"J Leffler","year":"2014","unstructured":"Leffler J, Bengtsson AA, Blom AM. The complement system in systemic lupus erythematosus: an update. Ann Rheum Dis. 2014;73(9):1601\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1554_CR6","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1042\/CS20160415","volume":"131","author":"M Weidenbusch","year":"2017","unstructured":"Weidenbusch M, Kulkarni OP, Anders H-J. The innate immune system in human systemic lupus erythematosus. Clin Sci. 2017;131(8):625\u201334.","journal-title":"Clin Sci"},{"key":"1554_CR7","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3389\/fimmu.2019.00772","volume":"10","author":"AA Herrada","year":"2019","unstructured":"Herrada AA, Escobedo N, Iruretagoyena M, Valenzuela RA, Burgos PI, Cuitino L, et al. Innate immune cells\u2019 contribution to systemic lupus erythematosus. Front Immunol. 2019;10:772.","journal-title":"Front Immunol"},{"issue":"5","key":"1554_CR8","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1600-0609.1969.tb02420.x","volume":"6","author":"L Brandt","year":"1969","unstructured":"Brandt L, Hedberg H. Impaired phagocytosis by peripheral blood granulocytes in systemic lupus erythematosus. Scand J Haematol. 1969;6(5):348\u201353.","journal-title":"Scand J Haematol"},{"issue":"6","key":"1554_CR9","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s10067-007-0768-x","volume":"27","author":"CM Alves","year":"2008","unstructured":"Alves CM, Marzocchi-Machado CM, Louzada-Junior P, Azzolini AE, Polizello AC, de Carvalho IF, et al. Superoxide anion production by neutrophils is associated with prevalent clinical manifestations in systemic lupus erythematosus. Clin Rheumatol. 2008;27(6):701\u20138.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"1554_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0002-9440(10)61689-6","volume":"159","author":"L Farkas","year":"2001","unstructured":"Farkas L, Beiske K, Lund-Johansen F, Brandtzaeg P, Jahnsen FL. Plasmacytoid dendritic cells (natural interferon- alpha\/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol. 2001;159(1):237\u201343.","journal-title":"Am J Pathol"},{"issue":"12","key":"1554_CR11","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1001\/archderm.136.12.1508","volume":"136","author":"DM Lipsker","year":"2000","unstructured":"Lipsker DM, Schreckenberg-Gilliot C, Uring-Lambert B, Meyer A, Hartmann D, Grosshans EM, et al. Lupus erythematosus associated with genetically determined deficiency of the second component of the complement. Arch Dermatol. 2000;136(12):1508\u201314.","journal-title":"Arch Dermatol"},{"issue":"9","key":"1554_CR12","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/1521-4141(200209)32:9<2672::AID-IMMU2672>3.0.CO;2-X","volume":"32","author":"E Paul","year":"2002","unstructured":"Paul E, Pozdnyakova OO, Mitchell E, Carroll MC. Anti-DNA autoreactivity in C4-deficient mice. Eur J Immunol. 2002;32(9):2672\u20139.","journal-title":"Eur J Immunol"},{"key":"1554_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fimmu.2016.00055","volume":"7","author":"AC Macedo","year":"2016","unstructured":"Macedo AC, Isaac L. Systemic lupus erythematosus and deficiencies of early components of the complement classical pathway. Front Immunol. 2016;7:55.","journal-title":"Front Immunol"},{"issue":"24","key":"1554_CR14","doi-asserted-by":"publisher","first-page":"6231","DOI":"10.3390\/ijms20246231","volume":"20","author":"DYH Yap","year":"2019","unstructured":"Yap DYH, Chan TM. B cell abnormalities in systemic lupus erythematosus and lupus nephritis-role in pathogenesis and effect of immunosuppressive treatments. Int J Mol Sci. 2019;20(24):6231.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1554_CR15","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41590-019-0398-x","volume":"20","author":"A Arazi","year":"2019","unstructured":"Arazi A, Rao DA, Berthier CC, Davidson A, Liu Y, Hoover PJ, et al. The immune cell landscape in kidneys of patients with lupus nephritis. Nat Immunol. 2019;20(7):902\u201314.","journal-title":"Nat Immunol"},{"issue":"4","key":"1554_CR16","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41581-019-0232-6","volume":"16","author":"DA Rao","year":"2020","unstructured":"Rao DA, Arazi A, Wofsy D, Diamond B. Design and application of single-cell RNA sequencing to study kidney immune cells in lupus nephritis. Nat Rev Nephrol. 2020;16(4):238\u201350.","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"1554_CR17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00251-019-01103-2","volume":"71","author":"A Javinani","year":"2019","unstructured":"Javinani A, Ashraf-Ganjouei A, Aslani S, Jamshidi A, Mahmoudi M. Exploring the etiopathogenesis of systemic lupus erythematosus: a genetic perspective. Immunogenetics. 2019;71(4):283\u201397.","journal-title":"Immunogenetics"},{"issue":"5","key":"1554_CR18","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1177\/0961203308089990","volume":"17","author":"LE Munoz","year":"2008","unstructured":"Munoz LE, van Bavel C, Franz S, Berden J, Herrmann M, Van Der Vlag J. Apoptosis in the pathogenesis of systemic lupus erythematosus. Lupus. 2008;17(5):371\u20135.","journal-title":"Lupus"},{"issue":"3","key":"1554_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1590\/S1807-59322010000300014","volume":"65","author":"BL Liphaus","year":"2010","unstructured":"Liphaus BL, Kiss MHB. The role of apoptosis proteins and complement components in the etiopathogenesis of systemic lupus erythematosus. Clinics. 2010;65(3):327\u201333.","journal-title":"Clinics"},{"issue":"3","key":"1554_CR20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/cdd.2009.195","volume":"17","author":"IK Poon","year":"2010","unstructured":"Poon IK, Hulett MD, Parish CR. Molecular mechanisms of late apoptotic\/necrotic cell clearance. Cell Death Differ. 2010;17(3):381\u201397.","journal-title":"Cell Death Differ"},{"key":"1554_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.clim.2016.07.015","volume":"185","author":"G Lorenz","year":"2017","unstructured":"Lorenz G, Lech M, Anders HJ. Toll-like receptor activation in the pathogenesis of lupus nephritis. Clin Immunol. 2017;185:86\u201394.","journal-title":"Clin Immunol"},{"issue":"10","key":"1554_CR22","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1136\/annrheumdis-2018-212988","volume":"77","author":"Y Kato","year":"2018","unstructured":"Kato Y, Park J, Takamatsu H, Konaka H, Aoki W, Aburaya S, et al. Apoptosis-derived membrane vesicles drive the cGAS\u2013STING pathway and enhance type I IFN production in systemic lupus erythematosus. Ann Rheum Dis. 2018;77(10):1507\u201315.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1554_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.molimm.2014.05.001","volume":"61","author":"BD Lyn-Cook","year":"2014","unstructured":"Lyn-Cook BD, Xie C, Oates J, Treadwell E, Word B, Hammons G, et al. Increased expression of Toll-like receptors (TLRs) 7 and 9 and other cytokines in systemic lupus erythematosus (SLE) patients: ethnic differences and potential new targets for therapeutic drugs. Mol Immunol. 2014;61(1):38\u201343.","journal-title":"Mol Immunol"},{"issue":"1","key":"1554_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12929-018-0436-2","volume":"25","author":"SK Devarapu","year":"2018","unstructured":"Devarapu SK, Anders H-J. Toll-like receptors in lupus nephritis. J Biomed Sci. 2018;25(1):35.","journal-title":"J Biomed Sci"},{"issue":"4","key":"1554_CR25","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/art.40396","volume":"70","author":"S Karrar","year":"2018","unstructured":"Karrar S, Graham DSC. Abnormal B cell development in systemic lupus erythematosus: what the genetics tell us. Arthritis Rheumatol (Hoboken, NJ). 2018;70(4):496.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"10","key":"1554_CR26","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1093\/rheumatology\/keaa060","volume":"59","author":"G Murayama","year":"2020","unstructured":"Murayama G, Chiba A, Kuga T, Makiyama A, Yamaji K, Tamura N, et al. Inhibition of mTOR suppresses IFN\u03b1 production and the STING pathway in monocytes from systemic lupus erythematosus patients. Rheumatology. 2020;59(10):2992\u20133002.","journal-title":"Rheumatology"},{"issue":"12","key":"1554_CR27","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/nri3921","volume":"15","author":"GN Barber","year":"2015","unstructured":"Barber GN. STING: infection, inflammation and cancer. Nat Rev Immunol. 2015;15(12):760\u201370.","journal-title":"Nat Rev Immunol"},{"key":"1554_CR28","doi-asserted-by":"crossref","unstructured":"Thim-Uam A, Prabakaran T, Tansakul M, Makjaroen J, Wongkongkathep P, Chantaravisoot N, et al. STING mediates lupus via the activation of conventional dendritic cell maturation and plasmacytoid dendritic cell differentiation. Iscience. 2020;23(9):101530.","DOI":"10.1016\/j.isci.2020.101530"},{"issue":"4","key":"1554_CR29","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jaut.2007.07.018","volume":"29","author":"KS Lang","year":"2007","unstructured":"Lang KS, Burow A, Kurrer M, Lang PA, Recher M. The role of the innate immune response in autoimmune disease. J Autoimmun. 2007;29(4):206\u201312.","journal-title":"J Autoimmun"},{"issue":"12","key":"1554_CR30","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.autrev.2012.03.004","volume":"11","author":"VS-F Chan","year":"2012","unstructured":"Chan VS-F, Nie Y-J, Shen N, Yan S, Mok M-Y, Lau C-S. Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus. Autoimmun Rev. 2012;11(12):890\u20137.","journal-title":"Autoimmun Rev"},{"key":"1554_CR31","doi-asserted-by":"publisher","first-page":"5045248","DOI":"10.1155\/2016\/5045248","volume":"2016","author":"J Klarquist","year":"2016","unstructured":"Klarquist J, Zhou Z, Shen N, Janssen EM. Dendritic cells in systemic lupus erythematosus: from pathogenic players to therapeutic tools. Mediators Inflamm. 2016;2016:5045248.","journal-title":"Mediators Inflamm"},{"issue":"1","key":"1554_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/imm.12888","volume":"154","author":"M Collin","year":"2018","unstructured":"Collin M, Bigley V. Human dendritic cell subsets: an update. Immunology. 2018;154(1):3\u201320.","journal-title":"Immunology"},{"issue":"1","key":"1554_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/08916934.2017.1280028","volume":"50","author":"SC Choi","year":"2017","unstructured":"Choi SC, Morel L. B cell contribution of the CD4(+) T cell inflammatory phenotypes in systemic lupus erythematosus. Autoimmunity. 2017;50(1):37\u201341.","journal-title":"Autoimmunity"},{"issue":"4","key":"1554_CR34","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/1529-0131(200104)44:4<856::AID-ANR142>3.0.CO;2-A","volume":"44","author":"C Scheinecker","year":"2001","unstructured":"Scheinecker C, Zwolfer B, Koller M, Manner G, Smolen JS. Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies. Arthritis Rheum. 2001;44(4):856\u201365.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"1554_CR35","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/S0198-8859(02)00756-5","volume":"63","author":"MA Gill","year":"2002","unstructured":"Gill MA, Blanco P, Arce E, Pascual V, Banchereau J, Palucka AK. Blood dendritic cells and DC-poietins in systemic lupus erythematosus. Hum Immunol. 2002;63(12):1172\u201380.","journal-title":"Hum Immunol"},{"issue":"3","key":"1554_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/09511920410001713538","volume":"13","author":"E Robak","year":"2004","unstructured":"Robak E, Smolewski P, Wozniacka A, Sysa-Jedrzejowska A, Robak T. Clinical significance of circulating dendritic cells in patients with systemic lupus erythematosus. Mediators Inflamm. 2004;13(3):171\u201380.","journal-title":"Mediators Inflamm"},{"issue":"9","key":"1554_CR37","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1002\/art.11225","volume":"48","author":"S Blomberg","year":"2003","unstructured":"Blomberg S, Eloranta ML, Magnusson M, Alm GV, Ronnblom L. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Rheum. 2003;48(9):2524\u201332.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1554_CR38","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.molimm.2007.04.029","volume":"45","author":"N Fiore","year":"2008","unstructured":"Fiore N, Castellano G, Blasi A, Capobianco C, Loverre A, Montinaro V, et al. Immature myeloid and plasmacytoid dendritic cells infiltrate renal tubulointerstitium in patients with lupus nephritis. Mol Immunol. 2008;45(1):259\u201365.","journal-title":"Mol Immunol"},{"issue":"1","key":"1554_CR39","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1046\/j.1365-2249.1999.00772.x","volume":"115","author":"H Vallin","year":"1999","unstructured":"Vallin H, Blomberg S, Alm GV, Cederblad B, Ronnblom L. Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-alpha) production acting on leucocytes resembling immature dendritic cells. Clin Exp Immunol. 1999;115(1):196\u2013202.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"1554_CR40","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1365-2249.2005.02897.x","volume":"142","author":"K Migita","year":"2005","unstructured":"Migita K, Miyashita T, Maeda Y, Kimura H, Nakamura M, Yatsuhashi H, et al. Reduced blood BDCA-2+ (lymphoid) and CD11c+ (myeloid) dendritic cells in systemic lupus erythematosus. Clin Exp Immunol. 2005;142(1):84\u201391.","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"1554_CR41","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1177\/0961203308089410","volume":"17","author":"O Jin","year":"2008","unstructured":"Jin O, Kavikondala S, Sun L, Fu R, Mok MY, Chan A, et al. Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression. Lupus. 2008;17(7):654\u201362.","journal-title":"Lupus"},{"issue":"3","key":"1554_CR42","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/sji.12330","volume":"82","author":"N Hagberg","year":"2015","unstructured":"Hagberg N, Ronnblom L. Systemic lupus erythematosus\u2013a disease with a dysregulated type I interferon system. Scand J Immunol. 2015;82(3):199\u2013207.","journal-title":"Scand J Immunol"},{"issue":"1","key":"1554_CR43","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/art.23186","volume":"58","author":"M Tucci","year":"2008","unstructured":"Tucci M, Quatraro C, Lombardi L, Pellegrino C, Dammacco F, Silvestris F. Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18. Arthritis Rheum. 2008;58(1):251\u201362.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1554_CR44","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/0961203312474704","volume":"22","author":"S Wu","year":"2013","unstructured":"Wu S, Yeh K, Lee W, Yao T, Kuo M, Huang B, et al. Impaired phagocytosis and susceptibility to infection in pediatric-onset systemic lupus erythematosus. Lupus. 2013;22(3):279\u201388.","journal-title":"Lupus"},{"issue":"3","key":"1554_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar4575","volume":"16","author":"AA Bengtsson","year":"2014","unstructured":"Bengtsson AA, Pettersson \u00c5, Wichert S, Gullstrand B, Hansson M, Hellmark T, et al. Low production of reactive oxygen species in granulocytes is associated with organ damage in systemic lupus erythematosus. Arthritis Res Ther. 2014;16(3):1\u20138.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"1554_CR46","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4049\/jimmunol.1100450","volume":"187","author":"E Villanueva","year":"2011","unstructured":"Villanueva E, Yalavarthi S, Berthier CC, Hodgin JB, Khandpur R, Lin AM, et al. Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J Immunol. 2011;187(1):538\u201352.","journal-title":"J Immunol"},{"key":"1554_CR47","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.freeradbiomed.2018.03.005","volume":"125","author":"J Zhong","year":"2018","unstructured":"Zhong J, Olsson LM, Urbonaviciute V, Yang M, B\u00e4ckdahl L, Holmdahl R. Association of NOX2 subunits genetic variants with autoimmune diseases. Free Radical Biol Med. 2018;125:72\u201380.","journal-title":"Free Radical Biol Med"},{"issue":"2","key":"1554_CR48","doi-asserted-by":"publisher","first-page":"E59","DOI":"10.1073\/pnas.1113251108","volume":"109","author":"CO Jacob","year":"2012","unstructured":"Jacob CO, Eisenstein M, Dinauer MC, Ming W, Liu Q, John S, et al. Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase. Proc Natl Acad Sci. 2012;109(2):E59\u201367.","journal-title":"Proc Natl Acad Sci"},{"issue":"9","key":"1554_CR49","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1136\/annrheumdis-2017-211287","volume":"76","author":"LM Olsson","year":"2017","unstructured":"Olsson LM, Johansson \u00c5C, Gullstrand B, J\u00f6nsen A, Saevarsdottir S, R\u00f6nnblom L, et al. A single nucleotide polymorphism in the NCF1 gene leading to reduced oxidative burst is associated with systemic lupus erythematosus. Ann Rheum Dis. 2017;76(9):1607\u201313.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1554_CR50","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/ng.3782","volume":"49","author":"J Zhao","year":"2017","unstructured":"Zhao J, Ma J, Deng Y, Kelly JA, Kim K, Bang S-Y, et al. A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases. Nat Genet. 2017;49(3):433\u20137.","journal-title":"Nat Genet"},{"issue":"1","key":"1554_CR51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41423-018-0024-0","volume":"16","author":"CM de Bont","year":"2019","unstructured":"de Bont CM, Boelens WC, Pruijn GJ. NETosis, complement, and coagulation: a triangular relationship. Cell Mol Immunol. 2019;16(1):19\u201327.","journal-title":"Cell Mol Immunol"},{"issue":"7","key":"1554_CR52","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.molmed.2017.05.006","volume":"23","author":"VR Moulton","year":"2017","unstructured":"Moulton VR, Suarez-Fueyo A, Meidan E, Li H, Mizui M, Tsokos GC. Pathogenesis of human systemic lupus erythematosus: a cellular perspective. Trends Mol Med. 2017;23(7):615\u201335.","journal-title":"Trends Mol Med"},{"issue":"13","key":"1554_CR53","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.4103\/0366-6999.235122","volume":"131","author":"Y He","year":"2018","unstructured":"He Y, Yang F-Y, Sun E-W. Neutrophil extracellular traps in autoimmune diseases. Chin Med J. 2018;131(13):1513.","journal-title":"Chin Med J"},{"issue":"3","key":"1554_CR54","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s12016-019-08773-6","volume":"59","author":"C Huang","year":"2020","unstructured":"Huang C, Li F, Wang J, Tian Z. Innate-like lymphocytes and innate lymphoid cells in asthma. Clin Rev Allergy Immunol. 2020;59(3):359\u201370.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"1554_CR55","first-page":"676","volume":"37","author":"M Hou","year":"2019","unstructured":"Hou M, Liu S. Innate lymphoid cells are increased in systemic lupus erythematosus. Clin Exp Rheumatol. 2019;37(4):676\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"1554_CR56","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.clim.2019.03.008","volume":"202","author":"C Guo","year":"2019","unstructured":"Guo C, Zhou M, Zhao S, Huang Y, Wang S, Fu R, et al. Innate lymphoid cell disturbance with increase in ILC1 in systemic lupus erythematosus. Clin Immunol. 2019;202:49\u201358.","journal-title":"Clin Immunol"},{"issue":"6","key":"1554_CR57","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1002\/art.30313","volume":"63","author":"B Hervier","year":"2011","unstructured":"Hervier B, Beziat V, Haroche J, Mathian A, Lebon P, Ghillani-Dalbin P, et al. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-\u03b3 production in patients with active disease. Arthritis Rheum. 2011;63(6):1698\u2013706.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"1554_CR58","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/sj.onc.1205179","volume":"21","author":"L Thyrell","year":"2002","unstructured":"Thyrell L, Erickson S, Zhivotovsky B, Pokrovskaja K, Sangfelt O, Castro J, et al. Mechanisms of interferon-alpha induced apoptosis in malignant cells. Oncogene. 2002;21(8):1251\u201362.","journal-title":"Oncogene"},{"issue":"4","key":"1554_CR59","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1189\/jlb.4RU0315-081RR","volume":"98","author":"R Spada","year":"2015","unstructured":"Spada R, Rojas JM, Barber DF. Recent findings on the role of natural killer cells in the pathogenesis of systemic lupus erythematosus. J Leukoc Biol. 2015;98(4):479\u201387.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"1554_CR60","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1365-2567.2008.02887.x","volume":"126","author":"D Schepis","year":"2009","unstructured":"Schepis D, Gunnarsson I, Eloranta ML, Lampa J, Jacobson SH, K\u00e4rre K, et al. Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus. Immunology. 2009;126(1):140\u20136.","journal-title":"Immunology"},{"key":"1554_CR61","first-page":"194","volume":"196","author":"KL Hudspeth","year":"2016","unstructured":"Hudspeth KL, Shu W, Wang J, Rahman S, Smith MA, Casey KA, et al. NK cell phenotype and proliferation in systemic lupus erythematosus. Am Assoc Immnol. 2016;196:194.","journal-title":"Am Assoc Immnol"},{"issue":"6","key":"1554_CR62","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s10067-013-2176-8","volume":"32","author":"A Henriques","year":"2013","unstructured":"Henriques A, Teixeira L, In\u00eas L, Carvalheiro T, Gon\u00e7alves A, Martinho A, et al. NK cells dysfunction in systemic lupus erythematosus: relation to disease activity. Clin Rheumatol. 2013;32(6):805\u201313.","journal-title":"Clin Rheumatol"},{"key":"1554_CR63","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3389\/fimmu.2019.01140","volume":"10","author":"W-T Ma","year":"2019","unstructured":"Ma W-T, Gao F, Gu K, Chen D-K. The role of monocytes and macrophages in autoimmune diseases: a comprehensive review. Front Immunol. 2019;10:1140.","journal-title":"Front Immunol"},{"issue":"1","key":"1554_CR64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar2584","volume":"11","author":"Y Li","year":"2009","unstructured":"Li Y, Lee PY, Sobel ES, Narain S, Satoh M, Segal MS, et al. Increased expression of Fc\u03b3RI\/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupus. Arthritis Res Ther. 2009;11(1):1\u201313.","journal-title":"Arthritis Res Ther"},{"key":"1554_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/385297","volume":"2014","author":"V Umare","year":"2014","unstructured":"Umare V, Pradhan V, Nadkar M, Rajadhyaksha A, Patwardhan M, Ghosh KK, et al. Effect of proinflammatory cytokines (IL-6, TNF-\u03b1, and IL-1\u03b2) on clinical manifestations in Indian SLE patients. Mediat Inflamm. 2014;2014:1\u20138.","journal-title":"Mediat Inflamm"},{"issue":"10","key":"1554_CR66","first-page":"703","volume":"18","author":"F Agha-Hosseini","year":"2015","unstructured":"Agha-Hosseini F, Moosavi M-S, Tabrizi MH. Comparison of oral lichen planus and systemic lupus erythematosus in interleukins level. Arch Iran Med (AIM). 2015;18(10):703.","journal-title":"Arch Iran Med (AIM)."},{"issue":"6","key":"1554_CR67","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.coi.2013.10.003","volume":"25","author":"C Pellefigues","year":"2013","unstructured":"Pellefigues C, Charles N. The deleterious role of basophils in systemic lupus erythematosus. Curr Opin Immunol. 2013;25(6):704\u201311.","journal-title":"Curr Opin Immunol"},{"issue":"10","key":"1554_CR68","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3390\/biology9100308","volume":"9","author":"K Dossybayeva","year":"2020","unstructured":"Dossybayeva K, Abdukhakimova D, Poddighe D. Basophils and systemic lupus erythematosus in murine models and human patients. Biology. 2020;9(10):308.","journal-title":"Biology"},{"key":"1554_CR69","volume-title":"Immunobiology: the immune system in health and disease","author":"C Janeway","year":"1999","unstructured":"Janeway C, Travers P, Capra JD, Walport M. Immunobiology: the immune system in health and disease. Current Biology Publications; 1999."},{"key":"1554_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/25785826.2020.1776079","volume":"44","author":"I Kurata","year":"2020","unstructured":"Kurata I, Matsumoto I, Sumida T. T follicular helper cell subsets: a potential key player in autoimmunity. Immunol Med. 2020;44:1\u20139.","journal-title":"Immunol Med"},{"issue":"3","key":"1554_CR71","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/cei.12903","volume":"187","author":"NS Lai","year":"2017","unstructured":"Lai NS, Koo M, Yu CL, Lu MC. Immunopathogenesis of systemic lupus erythematosus and rheumatoid arthritis: the role of aberrant expression of non-coding RNAs in T cells. Clin Exp Immunol. 2017;187(3):327\u201336.","journal-title":"Clin Exp Immunol"},{"key":"1554_CR72","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.clim.2017.07.004","volume":"183","author":"B Xu","year":"2017","unstructured":"Xu B, Wang S, Zhou M, Huang Y, Fu R, Guo C, et al. The ratio of circulating follicular T helper cell to follicular T regulatory cell is correlated with disease activity in systemic lupus erythematosus. Clin Immunol. 2017;183:46\u201353.","journal-title":"Clin Immunol"},{"issue":"2","key":"1554_CR73","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/eji.201545760","volume":"46","author":"P Blanco","year":"2016","unstructured":"Blanco P, Ueno H, Schmitt N. T follicular helper (Tfh) cells in lupus: activation and involvement in SLE pathogenesis. Eur J Immunol. 2016;46(2):281\u201390.","journal-title":"Eur J Immunol"},{"issue":"6","key":"1554_CR74","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.immuni.2015.05.012","volume":"42","author":"C Jacquemin","year":"2015","unstructured":"Jacquemin C, Schmitt N, Contin-Bordes C, Liu Y, Narayanan P, Seneschal J, et al. OX40 ligand contributes to human lupus pathogenesis by promoting T follicular helper response. Immunity. 2015;42(6):1159\u201370.","journal-title":"Immunity"},{"issue":"2","key":"1554_CR75","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1186\/ar2964","volume":"12","author":"K Shah","year":"2010","unstructured":"Shah K, Lee WW, Lee SH, Kim SH, Kang SW, Craft J, et al. Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus. Arthritis Res Ther. 2010;12(2):R53.","journal-title":"Arthritis Res Ther"},{"key":"1554_CR76","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.coi.2016.09.001","volume":"43","author":"A Suarez-Fueyo","year":"2016","unstructured":"Suarez-Fueyo A, Bradley SJ, Tsokos GC. T cells in systemic lupus erythematosus. Curr Opin Immunol. 2016;43:32\u20138.","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"1554_CR77","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/eji.201344280","volume":"45","author":"K Ohl","year":"2015","unstructured":"Ohl K, Tenbrock K. Regulatory T cells in systemic lupus erythematosus. Eur J Immunol. 2015;45(2):344\u201355.","journal-title":"Eur J Immunol"},{"key":"1554_CR78","doi-asserted-by":"publisher","first-page":"419029","DOI":"10.1155\/2014\/419029","volume":"2014","author":"A Mak","year":"2014","unstructured":"Mak A, Kow NY. The pathology of T cells in systemic lupus erythematosus. J Immunol Res. 2014;2014:419029.","journal-title":"J Immunol Res"},{"issue":"12","key":"1554_CR79","doi-asserted-by":"crossref","first-page":"8392","DOI":"10.4049\/jimmunol.175.12.8392","volume":"175","author":"M Miyara","year":"2005","unstructured":"Miyara M, Amoura Z, Parizot C, Badoual C, Dorgham K, Trad S, et al. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol (Baltimore). 2005;175(12):8392\u2013400.","journal-title":"J Immunol (Baltimore)."},{"key":"1554_CR80","doi-asserted-by":"publisher","first-page":"2932531","DOI":"10.1155\/2016\/2932531","volume":"2016","author":"M Wu","year":"2016","unstructured":"Wu M, Yang J, Li X, Chen J. The role of gammadelta T cells in systemic lupus erythematosus. J Immunol Res. 2016;2016:2932531.","journal-title":"J Immunol Res"},{"key":"1554_CR81","first-page":"1","volume":"2013","author":"Z Lu","year":"2013","unstructured":"Lu Z, Su D, Wang D, Li X, Feng X, Sun L. Elevated apoptosis and impaired proliferation contribute to downregulated peripheral \u03b3\u03b4 T cells in patients with systemic lupus erythematosus. Clin Dev Immunol. 2013;2013:1\u20133.","journal-title":"Clin Dev Immunol"},{"key":"1554_CR82","first-page":"405395","volume":"203","author":"Z Lu","year":"2013","unstructured":"Lu Z, Su D, Wang D, Li X, Feng X, Sun L. Elevated apoptosis and impaired proliferation contribute to downregulated peripheral gamma delta T cells in patients with systemic lupus erythematosus. Clin Dev Immunol. 2013;203:405395.","journal-title":"Clin Dev Immunol"},{"issue":"12","key":"1554_CR83","doi-asserted-by":"publisher","first-page":"6693","DOI":"10.4049\/jimmunol.1002776","volume":"186","author":"X Li","year":"2011","unstructured":"Li X, Kang N, Zhang X, Dong X, Wei W, Cui L, et al. Generation of human regulatory \u03b3\u03b4 T cells by TCR\u03b3\u03b4 stimulation in the presence of TGF-\u03b2 and their involvement in the pathogenesis of systemic lupus erythematosus. J Immunol. 2011;186(12):6693\u2013700.","journal-title":"J Immunol"},{"issue":"5","key":"1554_CR84","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/ar3433","volume":"13","author":"T D\u00f6rner","year":"2011","unstructured":"D\u00f6rner T, Giesecke C, Lipsky PE. Mechanisms of B cell autoimmunity in SLE. Arthritis Res Ther. 2011;13(5):243.","journal-title":"Arthritis Res Ther"},{"key":"1554_CR85","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3389\/fimmu.2015.00550","volume":"6","author":"TA Gottschalk","year":"2015","unstructured":"Gottschalk TA, Tsantikos E, Hibbs ML. Pathogenic inflammation and its therapeutic targeting in systemic lupus erythematosus. Front Immunol. 2015;6:550.","journal-title":"Front Immunol"},{"issue":"5","key":"1554_CR86","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1172\/JCI38010","volume":"119","author":"MP Cancro","year":"2009","unstructured":"Cancro MP, D\u2019Cruz DP, Khamashta MA. The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus. J Clin Investig. 2009;119(5):1066\u201373.","journal-title":"J Clin Investig"},{"issue":"1","key":"1554_CR87","doi-asserted-by":"publisher","first-page":"e000063","DOI":"10.1136\/lupus-2014-000063","volume":"2","author":"E Zollars","year":"2015","unstructured":"Zollars E, Bienkowska J, Czerkowicz J, Allaire N, Ranger AM, Magder L, et al. BAFF (B cell activating factor) transcript level in peripheral blood of patients with SLE is associated with same-day disease activity as well as global activity over the next year. Lupus Sci Med. 2015;2(1):e000063.","journal-title":"Lupus Sci Med"},{"key":"1554_CR88","first-page":"1","volume":"209","author":"T Wang","year":"2019","unstructured":"Wang T, Mei Y, Li Z. Research progress on regulatory B cells in systemic lupus erythematosus. BioMed Res Int. 2019;209:1\u20137.","journal-title":"BioMed Res Int"},{"key":"1554_CR89","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.intimp.2018.12.007","volume":"67","author":"X Cai","year":"2019","unstructured":"Cai X, Zhang L, Wei W. Regulatory B cells in inflammatory diseases and tumor. Int Immunopharmacol. 2019;67:281\u20136.","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"1554_CR90","doi-asserted-by":"publisher","first-page":"4801","DOI":"10.4049\/jimmunol.0902385","volume":"184","author":"R Watanabe","year":"2010","unstructured":"Watanabe R, Ishiura N, Nakashima H, Kuwano Y, Okochi H, Tamaki K, et al. Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J Immunol. 2010;184(9):4801\u20139.","journal-title":"J Immunol"},{"issue":"1","key":"1554_CR91","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jdermsci.2018.11.008","volume":"93","author":"T Matsushita","year":"2019","unstructured":"Matsushita T. Regulatory and effector B cells: friends or foes? J Dermatol Sci. 2019;93(1):2\u20137.","journal-title":"J Dermatol Sci"},{"key":"1554_CR92","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.3389\/fimmu.2019.01667","volume":"10","author":"X Wang","year":"2019","unstructured":"Wang X, Xia Y. Anti-double stranded DNA antibodies: origin, pathogenicity, and targeted therapies. Front Immunol. 2019;10:1667.","journal-title":"Front Immunol"},{"issue":"6","key":"1554_CR93","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/1744666X.2018.1473035","volume":"14","author":"CB Speyer","year":"2018","unstructured":"Speyer CB, Costenbader KH. Cigarette smoking and the pathogenesis of systemic lupus erythematosus. Expert Rev Clin Immunol. 2018;14(6):481\u20137.","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"1554_CR94","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/cr.2016.12","volume":"26","author":"J Bayry","year":"2016","unstructured":"Bayry J. Lupus pathogenesis: role of IgE autoantibodies. Cell Res. 2016;26(3):271.","journal-title":"Cell Res"},{"issue":"4","key":"1554_CR95","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.autrev.2017.11.027","volume":"17","author":"J-F Augusto","year":"2018","unstructured":"Augusto J-F, Truchetet M-E, Charles N, Blanco P, Richez C. IgE in lupus pathogenesis: friends or foes? Autoimmun Rev. 2018;17(4):361\u20135.","journal-title":"Autoimmun Rev"},{"key":"1554_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/176741","volume":"2013","author":"B Moudi","year":"2013","unstructured":"Moudi B, Salimi S, Farajian Mashhadi F, Sandoughi M, Zakeri Z. Association of FAS and FAS ligand genes polymorphism and risk of systemic lupus erythematosus. Sci World J. 2013;2013:1\u20133.","journal-title":"Sci World J"},{"key":"1554_CR97","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.autrev.2018.10.005","volume":"18","author":"E Toubi","year":"2019","unstructured":"Toubi E, Vadasz Z. Innate immune-responses and their role in driving autoimmunity. Autoimmun Rev. 2019;18:306.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"1554_CR98","doi-asserted-by":"publisher","first-page":"e000236","DOI":"10.1136\/lupus-2017-000236","volume":"4","author":"R Ramsey-Goldman","year":"2017","unstructured":"Ramsey-Goldman R, Li J, Dervieux T, Alexander RV. Cell-bound complement activation products in SLE. Lupus Sci Med. 2017;4(1):e000236.","journal-title":"Lupus Sci Med"},{"issue":"14","key":"1554_CR99","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1177\/0961203317709347","volume":"26","author":"M Hristova","year":"2017","unstructured":"Hristova M, Stoyanova V. Autoantibodies against complement components in systemic lupus erythematosus\u2013role in the pathogenesis and clinical manifestations. Lupus. 2017;26(14):1550\u20135.","journal-title":"Lupus"},{"issue":"8","key":"1554_CR100","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nrrheum.2010.56","volume":"6","author":"MC Pickering","year":"2010","unstructured":"Pickering MC, Botto M. Are anti-C1q antibodies different from other SLE autoantibodies? Nat Rev Rheumatol. 2010;6(8):490\u20133.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"1554_CR101","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000431278","volume":"1","author":"L Bao","year":"2015","unstructured":"Bao L, Cunningham PN, Quigg RJ. Complement in lupus nephritis: new perspectives. Kidney Dis (Basel). 2015;1(2):91\u20139.","journal-title":"Kidney Dis (Basel)"},{"key":"1554_CR102","doi-asserted-by":"crossref","unstructured":"Rojas M, Rodr\u00edguez Y, Leon KJ, Pacheco Y, Acosta-Ampudia Y, Monsalve DM, et al. Cytokines and inflammatory mediators in systemic lupus erythematosus. Rheumatology. 2018.","DOI":"10.33590\/emjrheumatol\/10311457"},{"key":"1554_CR103","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.coi.2016.10.006","volume":"44","author":"SK Panda","year":"2017","unstructured":"Panda SK, Kolbeck R, Sanjuan MA. Plasmacytoid dendritic cells in autoimmunity. Curr Opin Immunol. 2017;44:20\u20135.","journal-title":"Curr Opin Immunol"},{"issue":"7","key":"1554_CR104","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/s41590-019-0386-1","volume":"20","author":"E Der","year":"2019","unstructured":"Der E, Suryawanshi H, Morozov P, Kustagi M, Goilav B, Ranabothu S, et al. Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways. Nat Immunol. 2019;20(7):915\u201327.","journal-title":"Nat Immunol"},{"issue":"9","key":"1554_CR105","doi-asserted-by":"publisher","first-page":"e93009","DOI":"10.1172\/jci.insight.93009","volume":"2","author":"E Der","year":"2017","unstructured":"Der E, Ranabothu S, Suryawanshi H, Akat KM, Clancy R, Morozov P, et al. Single cell RNA sequencing to dissect the molecular heterogeneity in lupus nephritis. JCI Insight. 2017;2(9):e93009.","journal-title":"JCI Insight"},{"issue":"2","key":"1554_CR106","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.cyto.2015.01.031","volume":"73","author":"ES Robinson","year":"2015","unstructured":"Robinson ES, Werth VP. The role of cytokines in the pathogenesis of cutaneous lupus erythematosus. Cytokine. 2015;73(2):326\u201334.","journal-title":"Cytokine"},{"issue":"4","key":"1554_CR107","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/nep.12047","volume":"18","author":"DY Yap","year":"2013","unstructured":"Yap DY, Lai KN. The role of cytokines in the pathogenesis of systemic lupus erythematosus\u2014from bench to bedside. Nephrology (Carlton). 2013;18(4):243\u201355.","journal-title":"Nephrology (Carlton)"},{"key":"1554_CR108","doi-asserted-by":"publisher","first-page":"463412","DOI":"10.1155\/2011\/463412","volume":"2011","author":"A Okamoto","year":"2011","unstructured":"Okamoto A, Fujio K, Okamura T, Yamamoto K. Regulatory T-cell-associated cytokines in systemic lupus erythematosus. J Biomed Biotechnol. 2011;2011:463412.","journal-title":"J Biomed Biotechnol"},{"issue":"6","key":"1554_CR109","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1007\/s10753-013-9698-8","volume":"36","author":"S Mirkazemi","year":"2013","unstructured":"Mirkazemi S, Akbarian M, Jamshidi AR, Mansouri R, Ghoroghi S, Salimi Y, et al. Association of STAT4 rs7574865 with susceptibility to systemic lupus erythematosus in Iranian population. Inflammation. 2013;36(6):1548\u201352.","journal-title":"Inflammation"},{"key":"1554_CR110","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022236","author":"S Sanjabi","year":"2017","unstructured":"Sanjabi S, Oh SA, Li MO. Regulation of the immune response by TGF-beta: from conception to autoimmunity and infection. Cold Spring Harb Perspect Biol. 2017. https:\/\/doi.org\/10.1101\/cshperspect.a022236.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"10","key":"1554_CR111","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1089\/jir.2011.0047","volume":"31","author":"LS Davis","year":"2011","unstructured":"Davis LS, Hutcheson J, Mohan C. The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus. J Interferon Cytokine Res. 2011;31(10):781\u20139.","journal-title":"J Interferon Cytokine Res"},{"key":"1554_CR112","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3389\/fimmu.2018.01250","volume":"9","author":"R Mende","year":"2018","unstructured":"Mende R, Vincent FB, Kandane-Rathnayake R, Koelmeyer R, Lin E, Chang J, et al. Analysis of serum interleukin (IL)-1beta and IL-18 in systemic lupus erythematosus. Front Immunol. 2018;9:1250.","journal-title":"Front Immunol"},{"issue":"1","key":"1554_CR113","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12967-017-1345-y","volume":"15","author":"Y Pacheco","year":"2017","unstructured":"Pacheco Y, Barahona-Correa J, Monsalve DM, Acosta-Ampudia Y, Rojas M, Rodriguez Y, et al. Cytokine and autoantibody clusters interaction in systemic lupus erythematosus. J Transl Med. 2017;15(1):239.","journal-title":"J Transl Med"},{"issue":"10","key":"1554_CR114","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1007\/s00296-013-2784-2","volume":"33","author":"Z Tahmasebi","year":"2013","unstructured":"Tahmasebi Z, Akbarian M, Mirkazemi S, Shahlaee A, Alizadeh Z, Amirzargar AA, et al. Interleukin-1 gene cluster and IL-1 receptor polymorphisms in Iranian patients with systemic lupus erythematosus. Rheumatol Int. 2013;33(10):2591\u20136.","journal-title":"Rheumatol Int"},{"key":"1554_CR115","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/740619","author":"LA Lieberman","year":"2010","unstructured":"Lieberman LA, Tsokos GC. The IL-2 defect in systemic lupus erythematosus disease has an expansive effect on host immunity. J Biomed Biotechnol. 2010. https:\/\/doi.org\/10.1155\/2010\/740619.","journal-title":"J Biomed Biotechnol"},{"issue":"8","key":"1554_CR116","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/1440-1681.12946","volume":"45","author":"C Dong","year":"2018","unstructured":"Dong C, Fu T, Ji J, Li Z, Gu Z. The role of interleukin-4 in rheumatic diseases. Clin Exp Pharmacol Physiol. 2018;45(8):747\u201354.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"1554_CR117","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.imbio.2009.01.011","volume":"215","author":"N Rezaei","year":"2010","unstructured":"Rezaei N, Aghamohammadi A, Mahmoudi M, Shakiba Y, Kardar GA, Mahmoudi M, et al. Association of IL-4 and IL-10 gene promoter polymorphisms with common variable immunodeficiency. Immunobiology. 2010;215(1):81\u20137.","journal-title":"Immunobiology"},{"issue":"5","key":"1554_CR118","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/bjd.14703","volume":"175","author":"R Speeckaert","year":"2016","unstructured":"Speeckaert R, Lambert J, Grine L, Van Gele M, De Schepper S, van Geel N. The many faces of interleukin-17 in inflammatory skin diseases. Br J Dermatol. 2016;175(5):892\u2013901.","journal-title":"Br J Dermatol"},{"issue":"3","key":"1554_CR119","doi-asserted-by":"publisher","first-page":"903","DOI":"10.4049\/jimmunol.1700418","volume":"199","author":"H Dai","year":"2017","unstructured":"Dai H, He F, Tsokos GC, Kyttaris VC. IL-23 limits the production of IL-2 and promotes autoimmunity in lupus. J Immunol. 2017;199(3):903\u201310.","journal-title":"J Immunol"},{"key":"1554_CR120","doi-asserted-by":"publisher","first-page":"980286","DOI":"10.1155\/2011\/980286","volume":"2011","author":"K Miyake","year":"2011","unstructured":"Miyake K, Akahoshi M, Nakashima H. Th subset balance in lupus nephritis. J Biomed Biotechnol. 2011;2011:980286.","journal-title":"J Biomed Biotechnol"},{"issue":"2","key":"1554_CR121","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/BOR.0000000000000369","volume":"29","author":"MA Paley","year":"2017","unstructured":"Paley MA, Strand V, Kim AH. From mechanism to therapies in systemic lupus erythematosus. Curr Opin Rheumatol. 2017;29(2):178\u201386.","journal-title":"Curr Opin Rheumatol"},{"key":"1554_CR122","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.3389\/fimmu.2020.604000","volume":"11","author":"R Shepherd","year":"2021","unstructured":"Shepherd R, Cheung AS, Pang K, Saffery R, Novakovic B. Sexual dimorphism in innate immunity: the role of sex hormones and epigenetics. Front Immunol. 2021;11:3559.","journal-title":"Front Immunol"},{"key":"1554_CR123","doi-asserted-by":"publisher","first-page":"e7179","DOI":"10.7717\/peerj.7179","volume":"7","author":"Q Pan","year":"2019","unstructured":"Pan Q, Chen X, Liao S, Chen X, Zhao C, Xu Y-Z, et al. Updated advances of linking psychosocial factors and sex hormones with systemic lupus erythematosus susceptibility and development. PeerJ. 2019;7:e7179.","journal-title":"PeerJ"},{"issue":"9","key":"1554_CR124","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.tips.2013.07.003","volume":"34","author":"M Kadmiel","year":"2013","unstructured":"Kadmiel M, Cidlowski JA. Glucocorticoid receptor signaling in health and disease. Trends Pharmacol Sci. 2013;34(9):518\u201330.","journal-title":"Trends Pharmacol Sci"},{"issue":"2\u20133","key":"1554_CR125","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jsbmb.2010.03.058","volume":"120","author":"U Baschant","year":"2010","unstructured":"Baschant U, Tuckermann J. The role of the glucocorticoid receptor in inflammation and immunity. J Steroid Biochem Mol Biol. 2010;120(2\u20133):69\u201375.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"6","key":"1554_CR126","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.autrev.2010.11.009","volume":"10","author":"M Zen","year":"2011","unstructured":"Zen M, Canova M, Campana C, Bettio S, Nalotto L, Rampudda M, et al. The kaleidoscope of glucorticoid effects on immune system. Autoimmun Rev. 2011;10(6):305\u201310.","journal-title":"Autoimmun Rev"},{"key":"1554_CR127","unstructured":"Thau L, Gandhi J, Sharma S. Physiology, cortisol. StatPearls [Internet]. 2021."},{"issue":"6","key":"1554_CR128","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1191\/096120398678920343","volume":"7","author":"MA Guti\u00e9rrez","year":"1998","unstructured":"Guti\u00e9rrez MA, Garcia ME, Rodriguez JA, Rivero S, Jacobelli S. Hypothalamic-pituitary-adrenal axis function and prolactin secretion in systemic lupus erythematosus. Lupus. 1998;7(6):404\u20138.","journal-title":"Lupus"},{"issue":"2","key":"1554_CR129","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3899\/jrheum.100572","volume":"38","author":"MC van der Goes","year":"2011","unstructured":"van der Goes MC, Bossema ER, Hartkamp A, Godaert GLR, Jacobs JWG, Kruize AA, et al. Cortisol during the day in patients with systemic lupus erythematosus or primary sj\u00f6gren\u2019s syndrome. J Rheumatol. 2011;38(2):285\u20138.","journal-title":"J Rheumatol"},{"key":"1554_CR130","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9092709","author":"S Porta","year":"2020","unstructured":"Porta S, Danza A, Arias Saavedra M, Carlomagno A, Goizueta MC, Vivero F, et al. Glucocorticoids in systemic lupus erythematosus. Ten questions and some issues. J Clin Med. 2020. https:\/\/doi.org\/10.3390\/jcm9092709.","journal-title":"J Clin Med"},{"issue":"1","key":"1554_CR131","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/ajh\/hpaa137","volume":"34","author":"NS Ferreira","year":"2021","unstructured":"Ferreira NS, Tostes RC, Paradis P, Schiffrin EL. Aldosterone, inflammation, immune system, and hypertension. Am J Hypertens. 2021;34(1):15\u201327.","journal-title":"Am J Hypertens"},{"issue":"1","key":"1554_CR132","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1681\/ASN.2008020232","volume":"20","author":"V Leroy","year":"2009","unstructured":"Leroy V, De Seigneux S, Agassiz V, Hasler U, Rafestin-Oblin M-E, Vinciguerra M, et al. Aldosterone activates NF-\u03baB in the collecting duct. J Am Soc Nephrol. 2009;20(1):131\u201344.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"1554_CR133","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1097\/HJH.0b013e32834a4c75","volume":"29","author":"AA Herrada","year":"2011","unstructured":"Herrada AA, Campino C, Amador CA, Michea LF, Fardella CE, Kalergis AM. Aldosterone as a modulator of immunity: implications in the organ damage. J Hypertens. 2011;29(9):1684\u201392.","journal-title":"J Hypertens"},{"issue":"1","key":"1554_CR134","doi-asserted-by":"publisher","first-page":"R5","DOI":"10.1186\/ar2353","volume":"10","author":"SU Monrad","year":"2008","unstructured":"Monrad SU, Killen PD, Anderson MR, Bradke A, Kaplan MJ. The role of aldosterone blockade in murine lupus nephritis. Arthritis Res Ther. 2008;10(1):R5.","journal-title":"Arthritis Res Ther"},{"key":"1554_CR135","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.3389\/fimmu.2018.01332","volume":"9","author":"O Bereshchenko","year":"2018","unstructured":"Bereshchenko O, Bruscoli S, Riccardi C. Glucocorticoids, sex hormones, and immunity. Front Immunol. 2018;9:1332.","journal-title":"Front Immunol"},{"issue":"1","key":"1554_CR136","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.imlet.2010.07.001","volume":"133","author":"DA Gonzalez","year":"2010","unstructured":"Gonzalez DA, Diaz BB. Rodriguez Perez Mdel C, Hernandez AG, Chico BN, de Leon AC. Sex hormones and autoimmunity Immunol Lett. 2010;133(1):6\u201313.","journal-title":"Sex hormones and autoimmunity Immunol Lett"},{"key":"1554_CR137","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3389\/fimmu.2021.619268","volume":"12","author":"RP Singh","year":"2021","unstructured":"Singh RP, Bischoff DS. Sex hormones and gender influence the expression of markers of regulatory T cells in SLE patients. Front Immunol. 2021;12:408.","journal-title":"Front Immunol"},{"key":"1554_CR138","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/287469","author":"MV Legorreta-Haquet","year":"2013","unstructured":"Legorreta-Haquet MV, Flores-Fern\u00e1ndez R, Blanco-Favela F, Fuentes-Panan\u00e1 EM, Ch\u00e1vez-S\u00e1nchez L, Hern\u00e1ndez-Gonz\u00e1lez R, et al. Prolactin levels correlate with abnormal B cell maturation in MRL and MRL\/lpr mouse models of systemic lupus erythematosus-like disease. Clin Dev Immunol. 2013. https:\/\/doi.org\/10.1155\/2013\/287469.","journal-title":"Clin Dev Immunol"},{"issue":"4","key":"1554_CR139","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/imm.13119","volume":"158","author":"SC Funes","year":"2019","unstructured":"Funes SC, R\u00edos M, G\u00f3mez-Santander F, Fern\u00e1ndez-Fierro A, Altamirano-Lagos MJ, Rivera-Perez D, et al. Tolerogenic dendritic cell transfer ameliorates systemic lupus erythematosus in mice. Immunology. 2019;158(4):322\u201339.","journal-title":"Immunology"},{"issue":"2","key":"1554_CR140","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/1756-185X.12532","volume":"18","author":"MY Mok","year":"2015","unstructured":"Mok MY. Tolerogenic dendritic cells: role and therapeutic implications in systemic lupus erythematosus. Int J Rheum Dis. 2015;18(2):250\u20139.","journal-title":"Int J Rheum Dis"},{"issue":"10","key":"1554_CR141","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3390\/cells8101291","volume":"8","author":"P Ritprajak","year":"2019","unstructured":"Ritprajak P, Kaewraemruaen C, Hirankarn N. Current paradigms of tolerogenic dendritic cells and clinical implications for systemic lupus erythematosus. Cells. 2019;8(10):1291.","journal-title":"Cells"},{"issue":"7","key":"1554_CR142","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1002\/art.40828","volume":"71","author":"S Hasni","year":"2019","unstructured":"Hasni S, Gupta S, Davis M, Poncio E, Temesgen-Oyelakin Y, Joyal E, et al. Safety and tolerability of Omalizumab: a randomized clinical trial of humanized anti-IgE monoclonal antibody in systemic lupus erythematosus. Arthritis Rheumatol. 2019;71(7):1135\u201340.","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"1554_CR143","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jaci.2010.12.1087","volume":"127","author":"C Yildirim-Toruner","year":"2011","unstructured":"Yildirim-Toruner C, Diamond B. Current and novel therapeutics in the treatment of systemic lupus erythematosus. Journal of Allergy and Clinical Immunology. 2011;127(2):303\u201312.","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"1554_CR144","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1189\/jlb.5BT0615-234R","volume":"99","author":"A Barnado","year":"2016","unstructured":"Barnado A, Crofford LJ, Oates JC. At the bedside: neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases. J Leukoc Biol. 2016;99(2):265\u201378.","journal-title":"J Leukoc Biol"},{"issue":"2","key":"1554_CR145","first-page":"33","volume":"1","author":"R Salemme","year":"2019","unstructured":"Salemme R, Peralta LN, Meka SH, Pushpanathan N, Alexander JJ. The role of netosis in systemic lupus erythematosus. J Cell Immunol. 2019;1(2):33.","journal-title":"J Cell Immunol"},{"issue":"1","key":"1554_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08916930290005864","volume":"35","author":"AG Baxter","year":"2002","unstructured":"Baxter AG, Smyth MJ. The role of NK cells in autoimmune disease. Autoimmunity. 2002;35(1):1\u201314.","journal-title":"Autoimmunity"},{"key":"1554_CR147","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.3389\/fimmu.2018.02658","volume":"9","author":"M Vukelic","year":"2018","unstructured":"Vukelic M, Li Y, Kyttaris VC. Novel treatments in lupus. Front Immunol. 2018;9:2658.","journal-title":"Front Immunol"},{"issue":"4","key":"1554_CR148","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2217\/imt.10.29","volume":"2","author":"A La Cava","year":"2010","unstructured":"La Cava A. Anticytokine therapies in systemic lupus erythematosus. Immunotherapy. 2010;2(4):575\u201382.","journal-title":"Immunotherapy"},{"key":"1554_CR149","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/578641","author":"M Postal","year":"2012","unstructured":"Postal M, Costallat LT, Appenzeller S. Biological therapy in systemic lupus erythematosus. Int J Rheumatol. 2012. https:\/\/doi.org\/10.1155\/2012\/578641.","journal-title":"Int J Rheumatol"},{"issue":"7","key":"1554_CR150","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1517\/14712598.2016.1171840","volume":"16","author":"MY Mok","year":"2016","unstructured":"Mok MY, Shoenfeld Y. Recent advances and current state of immunotherapy in systemic lupus erythematosus. Expert Opin Biol Ther. 2016;16(7):927\u201339.","journal-title":"Expert Opin Biol Ther"},{"key":"1554_CR151","doi-asserted-by":"publisher","first-page":"465898","DOI":"10.1155\/2010\/465898","volume":"2010","author":"L-J Zhu","year":"2010","unstructured":"Zhu L-J, Yang X, Yu X-Q. Anti-TNF-alpha therapies in systemic lupus erythematosus. J Biomed Biotechnol. 2010;2010:465898.","journal-title":"J Biomed Biotechnol"},{"issue":"4","key":"1554_CR152","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.ejr.2015.02.001","volume":"37","author":"SA Metawie","year":"2015","unstructured":"Metawie SA, ElRefai RM, ElAdle SS, Shahin RMH. Transforming growth factor-\u03b21 in systemic lupus erythematosus patients and its relation to organ damage and disease activity. Egypt Rheumatol. 2015;37(4):S49\u201354.","journal-title":"Egypt Rheumatol"},{"issue":"1","key":"1554_CR153","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/annrheumdis-2019-215396","volume":"79","author":"J He","year":"2020","unstructured":"He J, Zhang R, Shao M, Zhao X, Miao M, Chen J, et al. Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial. Ann Rheum Dis. 2020;79(1):141\u20139.","journal-title":"Ann Rheum Dis"},{"key":"1554_CR154","doi-asserted-by":"publisher","first-page":"436450","DOI":"10.1155\/2015\/436450","volume":"2015","author":"H Zhang","year":"2015","unstructured":"Zhang H, Bernuzzi F, Lleo A, Ma X, Invernizzi P. Therapeutic potential of IL-17-mediated signaling pathway in autoimmune liver diseases. Mediat Inflamm. 2015;2015:436450.","journal-title":"Mediat Inflamm"},{"issue":"10","key":"1554_CR155","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1681\/ASN.2016040415","volume":"27","author":"SV Parikh","year":"2016","unstructured":"Parikh SV, Rovin BH. Current and emerging therapies for lupus nephritis. J Am Soc Nephrol. 2016;27(10):2929\u201339.","journal-title":"J Am Soc Nephrol"},{"key":"1554_CR156","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/823085","author":"A Alunno","year":"2012","unstructured":"Alunno A, Bartoloni E, Bistoni O, Nocentini G, Ronchetti S, Caterbi S, et al. Balance between regulatory T and Th17 cells in systemic lupus erythematosus: the old and the new. Clin Dev Immunol. 2012. https:\/\/doi.org\/10.1155\/2012\/823085.","journal-title":"Clin Dev Immunol"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-022-01554-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-022-01554-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-022-01554-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T12:24:38Z","timestamp":1726835078000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-022-01554-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,17]]},"references-count":156,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1554"],"URL":"https:\/\/doi.org\/10.1007\/s00011-022-01554-6","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,17]]},"assertion":[{"value":"17 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}